Literature DB >> 4950688

Superinfection with bacteriophage T4: inverse relationship between genetic exclusion and membrane association of deoxyribonucleic acid of secondary bacteriophage.

C J Sauri, C F Earhart.   

Abstract

The majority of the deoxyribonucleic acid (DNA) of superinfecting T4 bacteriophage which is injected and not hydrolyzed does not attach to host cell membrane. Low levels of association of secondary phage DNA with membrane appear to be related to temporal genetic exclusion.

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4950688      PMCID： PMC376275          DOI： 10.1128/JVI.8.6.856-859.1971

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  17 in total

1.  The release of enzymes by osmotic shock from Escherichia coli in exponential phase.

Authors:  N G Nossal; L A Heppel
Journal:  J Biol Chem       Date:  1966-07-10       Impact factor: 5.157

2.  The association of host and phage DNA with the membrane of Escherichia coli.

Authors:  C F Earhart
Journal:  Virology       Date:  1970-10       Impact factor: 3.616

3.  The relation between breakdown of superinfecting virus deoxyribonucleic acid and temporal exclusion induced by T4 and T5 bacteriophages.

Authors:  P E Fielding; M R Lunt
Journal:  J Gen Virol       Date:  1970-03       Impact factor: 3.891

4.  DNA replication studied by a new method for the isolation of cell membrane-DNA complexes.

Authors:  C F Earhart; G Y Tremblay; M J Daniels; M Schaechter
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1968

5.  Inhibition of T4 bacteriophage multiplication by superinfecting ghosts and the development of tolerance after bacteriophage infection.

Authors:  D H Duckworth
Journal:  J Virol       Date:  1971-01       Impact factor: 5.103

6.  Phospholipid metabolism in T4 bacteriophage infected Escherichia coli K-12 (lambda).

Authors:  R H Peterson; C S Buller
Journal:  J Virol       Date:  1969-05       Impact factor: 5.103

7.  Superinfection in bacteriophage S13 and determination of the number of bacteriophage particles which can function in an infected cell.

Authors:  E S Tessman; M T Borrás; I L Sun
Journal:  J Virol       Date:  1971-07       Impact factor: 5.103

8.  Phospholipid synthesis in Escherichia coli infected with T4 bacteriophages.

Authors:  M H Furrow; L I Pizer
Journal:  J Virol       Date:  1968-06       Impact factor: 5.103

9.  Cation fluxes and permeability changes accompanying bacteriophage infection of Escherichia coli.

Authors:  S Silver; E Levine; P M Spielman
Journal:  J Virol       Date:  1968-08       Impact factor: 5.103

10.  Host-controlled restriction of T-even bacteriophages: relation of four bacterial deoxyribonucleases to restriction.

Authors:  J Eigner; S Block
Journal:  J Virol       Date:  1968-04       Impact factor: 5.103
View more
  6 in total

1.  Selection for bacteriophage latent period length by bacterial density: A theoretical examination.

Authors:  S T Abedon
Journal:  Microb Ecol       Date:  1989-09       Impact factor: 4.552

2.  Superinfection exclusion by incomplete genomes of bacteriophage T4.

Authors:  J D Childs
Journal:  J Virol       Date:  1973-01       Impact factor: 5.103

3.  Effect of inhibition of macromolecule synthesis on the association of bacteriophage T4 DNA with membrane.

Authors:  C F Earhart; C J Sauri; G Fletcher; J L Wulff
Journal:  J Virol       Date:  1973-04       Impact factor: 5.103

4.  Mixed infections of Bacillus subtilis involving bacteriophage SPO2c 1 .

Authors:  P E Kolenbrander; H E Hemphill; H R Whiteley
Journal:  J Virol       Date:  1973-01       Impact factor: 5.103

5.  Breakdown and exclusion of superinfecting T-even bacteriophage in Escherichia coli.

Authors:  C W Anderson; J Eigner
Journal:  J Virol       Date:  1971-12       Impact factor: 5.103

6.  The Matrix Protein of a Plant Rhabdovirus Mediates Superinfection Exclusion by Inhibiting Viral Transcription.

Authors:  Xin Zhou; Kai Sun; Xueping Zhou; Andrew O Jackson; Zhenghe Li
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.